09 November 2018 - TRiNDS and Italfarmaco Announce US Patient Advocacy Partnership for EPIDYS Trial of Givinostat for Duchenne Muscular Dystrophy
Read more
26 September 2018 - New Marketing launch of SONIDOR, a food supplement based on hawthorn, lavender and hops extracts that induce sleep and relaxation
Read more
07 September 2018 - World Duchenne Awareness Day
Italfarmaco committed to its mission to contribute to the improvement of the quality and the prolongation of human lifespan, is proud to support the Duchenne Community and to recognize the World Duchenne Awareness Day.
Read more
25 July 2018 - World Drug Safety Congress Europe, 10-11 Settembre 2018, Amsterdam
Invited speaker: Margherita D’Antuono, QPPV Italfarmaco SpA
Read more
22 September 2017 - NATALBEN, line of pregnancy supplements of Italfarmaco, is the partner of Walking Day, the first Italian event dedicated to Walking
THE ART OF WALKING IN PREGNANCY IN THE WALKING DAY OF FLORENCE (October 1st) and MILAN (28/29 October)
Read more
21 September 2017 - ITF BECKER. A new therapeutic approach to the Becker Muscular Dystrophy (BMD)
Paolo Bettica, Vice President R&D ITALFARMACO S.p.A, interviewed for the ITF Becker project
Read more
27 June 2017 - A new therapeutic approach to the Becker muscular dypriophy, signed agreement
The signature meeting was held at the Regione Lombardia premises in the afternoon of June 27, 2017.
Read more
13 April 2017 - POR FESR 2014-2020: Linea innovazione (Innovation line)
The Italfarmaco's project "ITF-Becker a new therapeutic approach at the Becker Muscular Dystrophy (BMD)"
Read more
17 March 2017 - Peripheral occlusive arterial disease (PAD)
European objective of no amputations with early diagnosis and proper prevention; proper therapy could reduce amputations by 70%
Read more
02 March 2016 - Market launch of Akynzeo
Market launch of Akynzeo, new NK-1 antagonist serotonergic
Read more